ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 広島大学の刊行物
  2. Hiroshima Journal of Medical Sciences
  3. 52巻4号

Some Approaches to Treatment of Patients with Thyroid Nodular Diseases in the Semipalatinsk Region of Kazakhstan

https://hiroshima.repo.nii.ac.jp/records/2013540
https://hiroshima.repo.nii.ac.jp/records/2013540
8361c065-d884-4f86-8645-b0523430d2f1
名前 / ファイル ライセンス アクション
KJ00004267982.pdf KJ00004267982.pdf (2.5 MB)
Item type デフォルトアイテムタイプ_(フル)(1)
公開日 2023-03-18
タイトル
タイトル Some Approaches to Treatment of Patients with Thyroid Nodular Diseases in the Semipalatinsk Region of Kazakhstan
言語 en
作成者 Zhumadilov, Zhaxybay

× Zhumadilov, Zhaxybay

en Zhumadilov, Zhaxybay

Search repository
Hoshi, Masaharu

× Hoshi, Masaharu

en Hoshi, Masaharu

Search repository
Takeichi, Nobuo

× Takeichi, Nobuo

en Takeichi, Nobuo

Search repository
Abisheva, Gulniaz

× Abisheva, Gulniaz

en Abisheva, Gulniaz

Search repository
Taooka, Yasuyuki

× Taooka, Yasuyuki

en Taooka, Yasuyuki

Search repository
Bhattarcharjee, Deborshi

× Bhattarcharjee, Deborshi

en Bhattarcharjee, Deborshi

Search repository
Kamiya, Kenji

× Kamiya, Kenji

en Kamiya, Kenji

Search repository
アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
主題
主題Scheme Other
主題 Fallout Exposure
主題
主題Scheme Other
主題 Late effects
主題
主題Scheme Other
主題 Radiation-induced neoplasm
主題
主題Scheme Other
主題 Therapeutic approaches
主題
主題Scheme NDC
主題 490
内容記述
内容記述 It was determined by experts that in the region adjacent to the Semipalatinsk Nuclear Test Site thyroid nodular prevalence was significantly associated with radiation dose from nuclear weapons testing. The medical rehabilitation of patients is of special practical and scientific importance in this region. Some patients have contraindications for surgery and radioiodine or refuse them for various reasons. Percutaneous intranodular injection therapy by "Paoscle" (PIITP) was used for treatment of patients with benign thyroid nodular diseases. The study group included a total of 107 patients (mainly "pretoxic" and "compensated" nodules). Seventyfour patients received PIITP on an out-patient basis. Seventy-two of them were women and 2 men, mean age, 52.9±1.3 years; range 26 to 77 years. Thyroid ultrasound examination, fineneedle aspiration biopsy, thyroid function tests and cytopathology were performed in all patients to evaluate the effectiveness of treatment. The nodule volume reduction rate for patients with thyroid adenomas was 56% on average and 60.2% in the case of colloid nodules. The reduction rate of thyroid adenomas with necrotic and cystic degeneration was higher and reached 72%. The suggested method is indicated for cases of benign nodular thyroid diseases (cysts, adenomas, adenomas with necrotic and cystic degeneration, colloid nodules, polynodular goiter). We did not reveal any complications or thyroid test abnormalities after the treatment. A tendency to normalization of the blood serum thyroglobulin level and antibodies to thyroglobulin was documented. Analysis of the treatment results revealed that this approach is effective, inexpensive, safe, well tolerated and can be used on an outpatient basis.
言語 en
出版者
出版者 Hiroshima University Medical Press
出版者
出版者 国立情報学研究所
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ departmental bulletin paper
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
収録物識別子
収録物識別子タイプ ISSN
収録物識別子 0018-2052
収録物識別子
収録物識別子タイプ NCID
収録物識別子 AA00664312
開始ページ
開始ページ 81
書誌情報 Hiroshima Journal of Medical Sciences
Hiroshima Journal of Medical Sciences

巻 52, 号 4, p. 81-89, 発行日 2003-12
旧ID 17683
戻る
0
views
See details
Views

Versions

Ver.1 2025-02-23 06:36:19.300442
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3